Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Poller

Showing results (41-50 of 186) with videos related to

Pageof 19
Sort By:
Archives of Internal Medicine|July 24, 1995
Subcutaneous or intravenous phytonadione?J Hirsh, L Poller
Clinics in Laboratory Medicine|December 1, 1994
Laboratory monitoring of oral anticoagulant therapyL Poller, M Samama
British Medical Journal|August 27, 2010
Clothing factors during oral contraception: further reportL Poller, J M Thomson
British Dental Journal|March 10, 1984
Warfarin anticoagulant therapyL Poller, D A Taberner
Journal of Clinical Pathology|December 1, 1972
The partial thromboplastin (cephalin) time testL Poller, J M Thomson
British Journal of Haematology|September 1, 2001
Venous thrombosis and anticoagulant therapyP M Mannucci, L Poller
Lancet (London, England)|October 12, 1991
Setting the record straight on low-dose heparinL Poller, D A Taberner
Lancet (London, England)|October 16, 1976
Measuring partial thromboplastin-time. An international collaborative studyL Poller, J M Thomson
Journal of Clinical Pathology|November 1, 1972
A study of antiheparin activity of serum and platelet factor 4C H Sear, L Poller
Thrombosis Et Diathesis Haemorrhagica|September 15, 1973
Antiheparin activity of human serum and platelet factor 4C H Sear, L Poller
Pageof 19

Showing results (41-50 of 186) with videos related to

Sort By:
Pageof 19
Archives of Internal Medicine|July 24, 1995
Subcutaneous or intravenous phytonadione?J Hirsh, L Poller
Clinics in Laboratory Medicine|December 1, 1994
Laboratory monitoring of oral anticoagulant therapyL Poller, M Samama
British Medical Journal|August 27, 2010
Clothing factors during oral contraception: further reportL Poller, J M Thomson
British Dental Journal|March 10, 1984
Warfarin anticoagulant therapyL Poller, D A Taberner
Journal of Clinical Pathology|December 1, 1972
The partial thromboplastin (cephalin) time testL Poller, J M Thomson
British Journal of Haematology|September 1, 2001
Venous thrombosis and anticoagulant therapyP M Mannucci, L Poller
Lancet (London, England)|October 12, 1991
Setting the record straight on low-dose heparinL Poller, D A Taberner
Lancet (London, England)|October 16, 1976
Measuring partial thromboplastin-time. An international collaborative studyL Poller, J M Thomson
Journal of Clinical Pathology|November 1, 1972
A study of antiheparin activity of serum and platelet factor 4C H Sear, L Poller
Thrombosis Et Diathesis Haemorrhagica|September 15, 1973
Antiheparin activity of human serum and platelet factor 4C H Sear, L Poller
Pageof 19